Sign in
Back
Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
Journal article   Open access  Peer reviewed

Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine

Elham A AlQudari, Lulwah I Alabdan, Abdulla A Alkhathami, Mohammed D Alotaibi and Hanan A Alhamzi
Curēus (Palo Alto, CA), Vol.14(1), p.e21279
15/01/2022
DOI: https://doi.org/10.7759/cureus.21279
PMID: 35186544

Abstract

adult-onset still’s disease autoimmune disease covid 19 covid 19 side effect Infectious Disease Internal Medicine Rheumatology vaccine
Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challenging case of adult-onset Still's disease in a patient who recently received the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca).
url
https://doi.org/10.7759/cureus.21279View
Published (Version of record) Open

Metrics

1 Record Views

Details